Using the Appropriate Formula for QT Measurement Can Save Lives
CDK 4/6 inhibitors, in combination with endocrine therapy, are the standard of care for patients with endocrine- sensitive advanced breast cancer. This class of drug, however, is associated with QT prolongation, which serves as a surrogate marker for Torsades de Pointes (TdP), a cause of life-threat...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Серии: | Hematology/Oncology and Stem Cell Therapy |
| Предметы: | |
| Online-ссылка: | https://journals.lww.com/10.1016/j.hemonc.2021.06.001 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|